Nonetheless, independent and external confirmation was recently published by Liu and colleagues, suggesting broader applicability and validity in murine breast tumors, including loss of function leading to enhanced sensitivity to anti-PD-L1 (65). Here, CD274 is linked to breast neoplasm.